Accelrys Biological Registration: Mastering Biological R&D at Its Roots
White Paper Nov 25, 2010
This IDC Health Insights Perspective highlights a new product solution that promises to more effectively register, track, and manage promising biologics, resulting in more efficient biological product development and more systematic intellectual property management and protection. Accelrys' new Biological Registration system is the next step in the extension of its Accord chemical registration capabilities to biological entity registration. With the expanded product portfolio from its proposed merger with Symyx Technologies, Accelrys becomes the dominant industry leader for chemical and biological registration solutions, taking chemical and biologic entity management to a new level.
Related White Papers
Big Data Lipidomics for Lipid Biomarker Identification and Drug DiscoveryWhite Paper
Data analysis process aiming at the identification of lipid biomarkers and the
evaluations of their performance.
A Buyer's Guide to Protein Stability Measurement PlatformsWhite Paper
Malvern Instruments Limited
This buyer's guide discusses the available instrumentation for protein stability characterization, and what to consider when choosing stability assays.READ MORE
Advanced Analytics Architecture and the Benefits it Serves as an Integrated SolutionWhite Paper
Learn more about the system architecture of Advanced Analytics and the benefits it serves as an integrated solution.READ MORE